Peptide development is rarely straightforward. From insoluble sequences and impurity challenges to extended development timelines and regulatory hurdles, each step can introduce delays and risks that threaten your drug development program.
At Neuland Laboratories, we specialize in solving these complexities. With over 40 years of chemistry expertise, a team of 1,700+ scientific minds, and globally compliant cGMP manufacturing facilities, we empower pharma innovators and biotech companies to overcome the toughest peptide synthesis challenges.
Whether you're working with small molecule peptides, SPPS, LPPS, or hybrid approaches, our integrated capabilities ensure:
- Scalable and reproducible synthesis
- Rigorous impurity profiling and control
- Accelerated development timelines
- Regulatory-ready documentation and compliance
Guided by our vision of Creating a Healthier World, we deliver commercially viable peptide solutions that help you move from lab to market faster — and with confidence.
Why partner with us?
- 40+ years of experience– deep chemistry expertise built over decades of solving difficult synthesis and scale-up challenges.
- 1700+ employees driving innovation – a team of scientists, engineers, and regulatory experts dedicated to advancing your peptide program.
- Globally compliant infrastructure – multiple USFDA, EMA, and PMDA-approved facilities with capacity for mg to multi-kg GMP production.
- Speed + Compliance– Integrated services that reduces development timelines while ensuring global regulatory readiness.
-
Client-Centric Approach – transparent communication, flexible outsourcing models, and agile partnerships
Connect with Our Peptide Experts Today
Custom Peptide Services
Neuland’s custom peptide synthesis services cover all the pharmaceutical and biotech industry’s peptide requirements. We specialize in the clinical development of simple to complex peptides synthesis and their commercial-scale manufacturing.
Custom synthesis, route scouting, process development and validation, and impurity detection to ensure feasibility and optimization
Raw material vendor evaluation and qualification, ensuring seamless scale-up across lab production, pilots, and commercial manufacturing
Comprehensive manufacturing solutions across scale - from clinical trial batches to full- scale commercial production of complex amino acids and FMOC-building blocks
CMC preparation and review for peptide APIs, ensuring regulatory compliance with IMPD, IND, NDA, and ANDA registrations
Advanced R&D capabilities, including method validation, impurity profiling, and stability studies, supported by analytical reference standards
